Recent Updates
Recently added Catalysts
VTRS Neutral Sentiment

Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the Goldman Sachs 45th Annual Global...

Key Takeaway: Viatris Inc. (NASDAQ: VTRS) has announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference, scheduled for June 11, 2024, in Miami Beach, Florida. The company will be represented by its Chief Executive Officer Scott A. Smith and other executives in a fireside chat at 9:20 a.m. ET. Interested investors can access a live webcast of the event, with an archived version available afterward. This engagement is part of Viatris' broader mission to provide access to healthcare globally.
Price reaction · baseline $10.58 (2024-06-03 close) · hit after-hours · 1 other VTRS headline(s) in the window, move may be shared
day 0 close · peak
-0.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Viatris is participating in a major healthcare conference, which may enhance visibility.
  • Chief Executive Officer Scott A. Smith will represent the company, indicating leadership engagement.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+38%
120-day peak, hindsight
Typical move
1.6%
average across 12 past catalysts
Lead asset
Mylan's insulin glargine
Phase 3 · Type 1 Diabetes

Full Press Release Details

PITTSBURGH , June 4, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS ), a global healthcare company, today announced the company will participate in the Goldman Sachs 45 th Annual Global Healthcare Conference at the Loews Miami Beach Hotel in Miami Beach, Florida on Tuesday, June 11, 2024 . Chief Executive Officer Scott A Smith and Company executives will represent the company in a fireside chat scheduled at 9:20 a.m. ET .
Interested parties can access a live webcast of the event at investor.viatris.com . An archived version also will be available following the live event and can be accessed at the same location for a limited time.
About Viatris Viatris Inc . (NASDAQ: VTRS ) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh , Shanghai and Hyderabad, India . Learn more at viatris.com and investor.viatris.com , and connect with us on LinkedIn , Instagram , YouTube and X (formerly Twitter).

About Viatris Inc.

Ticker Symbol: VTRS
Exchange: NASDAQ
Mission: Empower people worldwide to live healthier at every stage of life
Patient Reach: ~1 billion patients annually
Global Centers: Pittsburgh, Shanghai, Hyderabad

Frequently Asked Questions

When will Viatris participate in the Goldman Sachs Conference?

Viatris will participate on June 11, 2024, at 9:20 a.m. ET.

Who will represent Viatris at the event?

CEO Scott A. Smith and other company executives will represent Viatris.

Where can I access the event webcast?

The live webcast can be accessed at investor.viatris.com.

What is the mission of Viatris?

Viatris aims to empower global health by providing access to quality medicines.

Where is Viatris headquartered?

Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai, and Hyderabad.

Last updated: Jun 4, 2024